Corpus ID: 25677470

The role of inflammation in heart failure: new therapeutic approaches.

@article{Oikonomou2011TheRO,
  title={The role of inflammation in heart failure: new therapeutic approaches.},
  author={Evangelos K. Oikonomou and Dimitris Tousoulis and Gerasimos Siasos and Marina Zaromitidou and Athanasios G. Papavassiliou and Christodoulos Stefanadis},
  journal={Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese},
  year={2011},
  volume={52 1},
  pages={
          30-40
        }
}
Hippokration Hospital 114 Vasilissis Sofias Ave. 115 28 Athens, Greece e-mail: drtousoulis@ hotmail.com 
Effect of enhanced external counterpulsation therapy on myeloperoxidase in lowering cardiovascular events of patients with chronic heart failure
TLDR
EECP therapy significantly decreased the level of MPO as inflammatory marker and this decrease was correlated with the reduction of cardiovascular events in CHF patients. Expand
Evaluation of Innate Immunity Biomarkers on Admission and at Discharge From an Acute Heart Failure Episode
TLDR
This work aims to evaluate how the prognostic value of some innate immunity markers vary on hospitalization due to an acute episode of HF and at discharge. Expand
Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?
TLDR
Comparing Sema4D and N terminal pro brain natriuretic peptide (NT‐proBNP) serum levels in heart failure patients to a control group is compared, and the correlation between Sema 4D and NT‐ proBNP levels is evaluated. Expand
Inflammation and Heart Failure
TLDR
The purpose of this chapter is to give a brief overview of the role of inflammation in heart failure from animal models to clinical disease. Expand
Cytokines: utility and laboratory
TLDR
Cytokines are soluble proteins that act as chemical messengers in the immune response and play an important role for communication with cells in other systems and in cell growth, differentiation, and hematopoisis. Expand
The Role of Interleukine - 6 and I nterleukin - 1 in failing heart
TLDR
It is concluded that the pro inflammatory interleuk ine - 6 (IL - 6) and interlukin - 1 ( IL - 1) may provoke the condition of heart failure patients. Expand
Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection
TLDR
Data suggest that serelaxin acts via multiple pathways to improve haemodynamics at the vascular, cardiac, and renal level and provide effective congestion relief, and may protect the heart, kidneys, and liver from damage by inhibiting inflammation, oxidative stress, cell death, and tissue fibrosis, and stimulating angiogenesis. Expand
Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
TLDR
Treatment with ivabradine in patients with CHF resulted in an improvement of HF symptoms and ejection fraction as well as a normalization of inflammatory mediators, leading to a significant reduction of TNF-alpha (TNF-α) serum levels and a reconstitution of circulating dendritic cells which are known to be reduced in patientswith CHF. Expand
Management of psoriasis as a systemic disease: what is the evidence?
  • N. Korman
  • Medicine
  • The British journal of dermatology
  • 2019
Psoriasis is a chronic, systemic immune‐mediated disease characterized by development of erythematous, indurated, scaly, pruritic and often painful skin plaques. Psoriasis pathogenesis is driven byExpand
Galectin-3: a novel biomarker for the prognosis of heart failure
TLDR
Galectin-3 has some advantages such as more stability and resistance against hemodynamic loading and unloading state, and also it could act as an early indicator of cardiac fibrosis, ventricular remodeling, and renal impairment in HF patients. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 121 REFERENCES
Blockade of NF-κB improves cardiac function and survival after myocardial infarction
TLDR
The hypothesis that blockade of NF-κB is a key transcription factor that regulates inflammatory processes is tested and it is shown that it ameliorates cardiac remodeling and failure after myopathy. Expand
Serum markers of angiogenesis and myocardial ultrasonic tissue characterization in patients with dilated cardiomyopathy
TLDR
The relationship between serum activity of angiogenic factors and myocardial ultrasonic tissue characterization in patients with idiopathic dilated cardiomyopathy was evaluated. Expand
C‐reactive protein as a predictor of improvement and readmission in heart failure
TLDR
This study was aimed at investigating C‐reactive protein (CRP), a marker of systemic inflammation, in the context of heart failure, and to determine its usefulness in predicting the need for readmission in patients with heart failure and their degree of improvement. Expand
Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease.
To the Editor: Resistin is an adipocytokine that may link obesity with insulin resistance and diabetes. Steppan et al. ([1][1]) reported serum resistin levels to be elevated in obese mice and to beExpand
New therapeutics for chronic heart failure.
TLDR
The rationale for existing heart failure therapies is reviewed and the reasoning behind the development of some emerging therapies is discussed, in which heart failure progresses because of the toxic effects of endogenous biological systems that become activated in heart failure. Expand
Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.
TLDR
Short-term treatment with rosuvastatin regulates inflammatory process in patients with heart failure by significantly reducing plasma levels of myeloperoxidase, and provides further insights into the pathophysiological mechanisms of MPO in heart failure. Expand
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction.
TLDR
Osteoprotegerin is a novel marker for cardiovascular mortality and clinical events in patients with AMI complicated with HF, compatible with the hypothesis suggesting a possible association between mediators of bone homeostasis and cardiovascular disease. Expand
Statins in Heart Failure.
TLDR
Evidence that statin therapy is associated with a significant reduction in cardiovascular morbidity and mortality when used for either primary or secondary prevention of cardiovascular events is summarized. Expand
Anemia in chronic heart failure: pathogenetic mechanisms.
TLDR
Investigation of the mechanisms of anemia in chronic heart failure suggests proinflammatory cytokines are likely to play a significant role by generating the "anemia of chronic illness" that is a hallmark of inflammatory conditions. Expand
Cytokines, apoptosis and cachexia: the potential for TNF antagonism.
TLDR
The aim of this article is to review the role of inflammatory cytokines, particularly TNF, in the pathogenesis of wasting and also the potential for anti-cytokine therapy. Expand
...
1
2
3
4
5
...